SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IRWIN JAMES FRANKEL who wrote (3074)10/9/2013 10:25:23 AM
From: Biotech Jim  Read Replies (1) of 3661
 
I had some shares of ARIA, and I am not that clued in on the programs, nor on the cardiac events observed with Iclusiv. My question, one that could have been asked at the CC, is whether the events observed are mechanistic or not. If mechanistic on Tyrosine Kinase enzymes/receptors, then will the lowering of dose to 30mg or 15 mg get around perhaps some target that is more weakly inhibited than the oncology targets? I will listen to the CC later.

Perhaps Peter can weigh in?

I dumped most of my shares this morning. Obviously the 3 day buy rule should be in effect here. Market cap now around $800M?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News